切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2016, Vol. 13 ›› Issue (01) : 56 -60. doi: 10.3877/cma.j.issn.1672-6448.2016.01.014

所属专题: 文献

腹部超声影像学

实时导航超声造影在小肝癌诊断中的应用研究
王文平1,(), 季正标1, 董怡1, 毛枫1, 张小龙1, 李翠仙1   
  1. 1. 200032 上海,复旦大学附属中山医院超声科 复旦大学超声医学与工程研究所
  • 收稿日期:2015-08-06 出版日期:2016-01-01
  • 通信作者: 王文平
  • 基金资助:
    国家自然科学基金项目(81371577,81571676)

Application of volume navigation guided real time contrast-enhanced ultrasound for diagnosis of small malignant hepatic lesions

Wenping Wang1,(), Zhengbiao Ji1, Yi Dong1, Feng Mao1, Xiaolong Zhang1, Cuixian Li1   

  1. 1. Department of Ultrasound, Zhongshan Hospital, Institute of Medical Ultrasound and Engineering, Fudan University, Shanghai 200032, China
  • Received:2015-08-06 Published:2016-01-01
  • Corresponding author: Wenping Wang
  • About author:
    Corresponding author: Wang Wenping, Email:
引用本文:

王文平, 季正标, 董怡, 毛枫, 张小龙, 李翠仙. 实时导航超声造影在小肝癌诊断中的应用研究[J/OL]. 中华医学超声杂志(电子版), 2016, 13(01): 56-60.

Wenping Wang, Zhengbiao Ji, Yi Dong, Feng Mao, Xiaolong Zhang, Cuixian Li. Application of volume navigation guided real time contrast-enhanced ultrasound for diagnosis of small malignant hepatic lesions[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2016, 13(01): 56-60.

目的

探讨超声造影(CEUS)联合磁共振成像(MRI)实时导航技术在小肝癌诊断中的应用。

方法

收集2008年1月至2015年6月复旦大学附属中山医院门诊及住院的临床疑诊为小肝癌(直径小于20 mm)的患者50例,共50个病灶,所有患者在常规超声检查未发现病灶,而增强MRI均提示有小肝癌。采用GE公司LOGIQ E9超声诊断仪,配备超声造影与MRI导航技术。超声造影采用低机械指数下实时灰阶超声造影(MI 0.05~0.12),每次造影经肘静脉团注1.5~2.4 ml造影剂SonoVue。

结果

所有病灶均经手术、活检或其他影像学检查证实为肝癌,其中原发性肝癌45个,转移性肝癌5个。实时导航超声造影时,50例患者均成功完成图像融合,融合成功率100%,平均融合时间为(9.1±0.5)min。在50个病灶中,常规超声造影发现15个病灶(30%,15/50),实时导航超声造影检出48个病灶(96%,48/50),两者比较差异具有统计学意义(Z=1.73,P<0.05)。在实时导航超声造影中,46个(92.0%,46/50)病灶表现为动脉期快速增强,4个病灶(8%,4/50)呈同步增强;28个病灶在门脉期呈等回声(56%,28/50),超声造影联合MRI实时导航成像技术检出48个病灶(96%,48/50),2个未能显示的病灶经人工胸水后再次实时导航顺利检出。实时导航超声造影对本组小肝癌的检出率及诊断准确性为100%。

结论

实时导航超声造影可显著提高小肝癌检出率和诊断准确性。

Objective

To evaluate whether volume navigation guided real time contrast-enhanced ultrasound (CEUS) can be performed effectively in diagnosis of small malignant hepatic lesions.

Methods

Fifty patients with suspected small malignant hepatic lesions was included in this study. Tumor diameters were small than 20 mm. All lesions were detected by contrast-enhanced MR imaging (MRI) but were undetectable on conventional ultrasound. LOGIQ E9 ultrasound system (GE Healthcare) equipped with volume navigation system was used to fuse CEUS and MRI images. CEUS was performed using real time contrast harmonic imaging at a low MI 0.05-0.12 with a 1.5-5.0 MHz probe. For each imaging session, a dose of 1.5-2.4 ml SonoVue was injected as a quick bolus into the antecubital vein.

Results

Consequently, fifty small malignant hepatic lesions in 50 patients were included in this study. The final diagnoses were confirmed by operation, percutaneous biopsy or radiological data, including 45 primary and 5 metastatic hepatic carcinomas. Image fusions were conducted successfully in all 50 lesions and the technical success rate was 100%. The average fusion time was (9.1±0.5) min. The detection rate of small malignant hepatic lesions using CEUS/MRI imaging fusion (96.0%, 48/50) was significantly higher than that of conventional CEUS (30.0%, 15/50) (Z=1.73, P<0.05). After injection of SonoVue, 46 (92.0%, 46/50) small malignant hepatic lesions displayed rapid wash-in pattern in the arterial phase of CEUS/MRI imaging fusion, and 4 lesions (8.0%, 4/50) showed synchronous enhancement. In the portal venous phase, 28 (56.0%, 28/50) lesions showed iso-enhancement comparing to the surrounding liver parenchyma. CEUS/MRI imaging fusion detected 48 lesions (96.0%, 48/50). After artificial pleural effusion, another 2 nodules were clearly detected. In our current research, the detection rate and diagnostic accuracy of CEUS/MRI imaging fusion were 100%.

Conclusion

Imaging fusion combining CEUS with MRI is a promising technique to improve the detection rate and accurate diagnosis of small malignant hepatic lesions.

图1 实时导航超声造影显示动脉期增强门脉期呈等回声的小肝癌
图2 实时导航超声造影显示动脉期显著强化的肝右叶等回声小肝癌
[1]
Yoon SH, Lee KH, Kim SY, et al. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound [J]. Eur Radiol, 2010, 20(8): 2047-2056.
[2]
Takayama T, Makuuchi M, Kojiro M, et al. Early hepatocellular carcinoma: pathology, imaging, and therapy [J]. Ann SurgOncol, 2008, 15(4): 972-978.
[3]
Xie L, Guang Y, Ding H, et al. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis [J]. Ultrasound Med Biol, 2011, 37(6):854-861.
[4]
Kim PN, Choi D, Rhim H, et al. Planning ultrasound for percutaneous radiofrequency ablation to treat small ( ≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility [J]. J Vasc Interv Radiol, 2012, 23(5): 627-634.
[5]
Lee MW, Kim YJ, Park HS, et al. Targeted sonographyfor small hepatocellular carcinoma discoveredby CT or MRI: factors affecting sonographicdetection [J]. AJR Am J Roentgenol, 2010, 194(5): W396-400.
[6]
Park HJ, Lee MW, Lee MH, et al. Fusion imaging-guided percutaneous biopsy of focal hepatic lesions with poor conspicuity on conventional sonography [J]. J Ultrasound Med, 2013, 32(9):1557-1564.
[7]
Wilson SR, Burns PN. Microbubble-enhanced US in body imaging: What role? [J]. Radiology, 2010, 257(1): 24-39.
[8]
王文平, 魏瑞雪, 李超伦, 等. 超声造影诊断复发性肝细胞肝癌的研究[J/CD]. 中华医学超声杂志:电子版, 2010, 7(1): 10-14.
[9]
丁红, 王文平, 魏瑞雪, 等. 超声造影评估初发性与复发性小肝癌的血流动力学比较研究[J/CD]. 中华临床医师杂志:电子版, 2013, 7(2): 19-21.
[10]
Bruix J, Sherman M. American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma: an update [J]. Hepatology, 2011, 53(3): 1020-1022.
[11]
Jung EM, Friedrich C, Hoffstetter P, et al. Volume navigation with contrast enhanced ultrasound and image fusion for percutaneous interventions: first results [J]. PLoS One, 2012, 7(3):e33956.
[12]
Milot L, Ma K, Efford E, et al. Evaluation of a multimodality MR/US coregistration system for investigation of hepatic metastases from colorectal cancer [J]. J Vasc Interv Radiol, 2013, 24(3): 357-362.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 宋勇, 李东炫, 王翔, 李锐. 基于数据挖掘法分析3 种超声造影剂不良反应信号[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 890-898.
[6] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[7] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[8] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[9] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[12] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[13] 陈意志. 核磁共振钆造影剂导致的肾源性系统性纤维化[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 358-358.
[14] 张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.
[15] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
阅读次数
全文


摘要